GYRE THERAPEUTICS, INC. ($GYRE)
Filing Information
| Accession Number | 0001140361-26-024449 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 8, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
104,928
Total Value
$244,793.15
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jun 4, 2026 | Exercise/Conversion | 19,575 | $0.75 | $14,681.25 | 719,575 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 4, 2026 | Sale | 19,575 | $6.13 | $119,994.75 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 5, 2026 | Exercise/Conversion | 15,401 | $0.75 | $11,550.75 | 715,401 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 5, 2026 | Sale | 15,401 | $6.40 | $98,566.40 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jun 4, 2026 | Exercise/Conversion | 19,575 | $0.00 | $0.00 | 877,820 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jun 5, 2026 | Exercise/Conversion | 15,401 | $0.00 | $0.00 | 862,419 | Direct | โ | View Details |